š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This was a study of the effects of VIVITROLĀ® on alcohol cue-induced craving...
Status
Completed
Location
McLean Hospital
Start Date
2007-07
Trial ID
NCT00511836
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of Me...
Status
Completed
Location
Alkermes Clinical Study Site
Start Date
2009-03
Trial ID
NCT00834080
Treatments Being Tested
This study seeks to compare the effectiveness of two medications used to tr...
Status
Completed
Location
Yale University School of Medicine
Start Date
2021-01-07
Trial ID
NCT04219540
Treatments Being Tested
This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Status
Completed
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Start Date
2017-05-05
Trial ID
NCT03078075
Treatments Being Tested
To evaluate the efficacy of VIVITROL (naltrexone for extended-release injec...
Status
Completed
Location
University of Pennsylvania
Start Date
2009-07
Trial ID
NCT00777062
Treatments Being Tested
This was a Phase 3, multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT01218958
The purpose of this study is to evaluate a very low dose naltrexone-bupreno...
Status
Completed
Location
Duke University Medical Center / Civitan Building
Start Date
2012-09
Trial ID
NCT01690546
Treatments Being Tested
VIVITROL is indicated for the treatment of alcohol dependence in patients w...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00501631
Treatments Being Tested
This is a Phase 3 multi-center trial designed to evaluate the clinical effi...
Status
Completed
Location
Ethics Committee within the Federal Authority for Healthcare and Social Development Regulation
Start Date
2008-06
Trial ID
NCT00678418
Treatments Being Tested
This was a multicenter extension of Alkermes' Study ALK21-006 (NCT01218997)...
Status
Terminated
Location
Multiple Locations
Start Date
2004-08
Trial ID
NCT00156936
Treatments Being Tested